TMEM217B
Transmembrane protein 217B
Also known as: T217B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A0A494BZU4
- Gene
- TMEM217B
- Ensembl
- ENSG00000286105
- Chromosome
- 6
- Canonical length
- 170 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
170 residues, UniProt reviewed canonical sequence.
>A0A494BZU4|TMEM217B
1 MNVRMFSLMV GIFSVLNTTQ FFIFDLNQKT HICYEAKFSI YVDSKSELVT WTLFHRANIS
61 TGLSLTTIII GCFLFYCIHK NIYMGLLIYA MWIITYELIN FSIVLLLNGI IKDHFKTLSY
121 LHWIFQISHM LLHFFCLPFI VKHAYNLYKE SQTVGRKRRH RLCSTIAVNSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM217B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 9.9 nTPM
Expression across tissuesHPA
Tissue
- testis: 9.9 nTPM
- adrenal gland: 1 nTPM
- salivary gland: 1 nTPM
- esophagus: 0.9 nTPM
- bone marrow: 0.7 nTPM
- lung: 0.6 nTPM
Single-cell type
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
- b-cells: 0 nCPM
Immune cell
- basophil: 0.4 nTPM
- memory CD8 T-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- T-reg: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- thalamus: 0.5 nTPM
- cerebral cortex: 0.4 nTPM
- basal ganglia: 0.2 nTPM
- hippocampal formation: 0.2 nTPM
- hypothalamus: 0.2 nTPM
- pons: 0.2 nTPM
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM217B as an antibody target. Whether an autoantibody or antibody against TMEM217B could matter depends on whether native TMEM217B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM217B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM217B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...